Thanks for your response. Presuming good phase 2 data across the board, I was thinking that the sell of IPIX could command a price so high, perhaps $10-$20B, that no big pharma would be willing to assume that much risk.
On the other hand, if Leo decides to sell by indication/platform or form a partnership(s) it might yield more than my earlier estimate.
At any rate, we should know shortly which route or routes Leo will take.
Message in reply to:
Leo will want a lot of money. My guess is at least $10 billion. Leo has said repeatedly that the further along the more they are worth.
News 
Market Data 
Discover 
